What's new in transplant immunology: Problems and prospects

Annals of Internal Medicine

Volumn 128, Issue 11, 1998, Pages 946-948

  Turka, Laurence A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION;

EID: 0032104149     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-128-11-199806010-00015     Document Type: Review

References (22)

1. Morris PJ. Results of renal transplantation. In: Morris PJ, ed. Kidney Transplantation: Principles and Practice. 4th ed. Philadelphia: WB Saunders; 1994: 524-31.
2. Paul LC, Tilney NL. Alloantigen-dependent events in chronic rejection. In: Tilney NL, Strom TB, Paul LC, eds. Transplantation Biology: Cellular and Molecular Aspects. Philadelphia: Lippincott-Raven; 1996:567-75.
3. Bierer B. Advances in therapeutic immunosuppression: biology, molecular actions, and clinical implications. Curr Opin Hematol. 1993:149-59.
4. Kahan BD. Cyclosporine. N Engl J Med. 1989;321:1725-38.
5. Morris R. Rapamycins: antifungal, antitumor, antiproliferative and immunosuppressive macrolides. Transplantation Reviews. 1992;6:39-87.
6. Lui SL, Halloran PF. Mycophenolate mofetil in kidney transplantation. Curr Opin Nephrol Hypertens. 1996;5:508-13.
7. Gjertson DW, Cecka JM, Terasaki Pl. The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation. 1995;60:1384-8.
8. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation. 1995;59:313-8.
9. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168-70.
10. Sykes M, Sachs DH. Bone marrow transplantation as a means of inducing tolerance. Semin Immunol. 1990;2:401-17.
11. Posselt AM, Barker CF, Friedman AL, Naji A. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science. 1992;256:1321-4.
12. Posselt AM. Barker CF, Tomaszewski JE, Markmann JF, Choti MA, Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science. 1990;249:1293-5.
13. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 1994;76:275-85.
14. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today. 1994;15:321-31.
15. Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4lg plus donor-specific transfusion. J Exp Med. 1993;178:1801-6.
16. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996;381:434-8.
17. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, et al. CTLA4-lg and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A. 1997;94:8789-94.
18. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today. 1993;14:326-32.
19. Starzl TE, Demetris AJ, Murase N, lldstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 1992;339:1579-82.
20. Elwood ET, Larsen CP, Maurer DH, Routenberg KL, Neylan JF, Whelchel JD, et al. Microchimerism and rejection in clinical transplantation. Lancet. 1997;349:1358-60.
21. Garcia-Morales R, Carreno M, Mathew J, Zucker K, Cirocco R, Ciancio G, et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest. 1997;99:1118-29.
22. Lau HT, Yu M, Fontana A, Stoeckert J, Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science. 1996;273: 109-12.